Akebia director granted RSUs and stock options
Akebia Therapeutics director Cynthia Smith received new equity awards as part of non-employee director compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Akebia Therapeutics director Cynthia Smith received new equity awards as part of non-employee director compensation. She was granted 35,700 restricted stock units and an option for 53,600 shares of common stock at an exercise price of $1.02 per share. Both awards vest 100% on the first anniversary of the June 17, 2026 grant date, or earlier immediately before the next annual stockholder meeting, if she continues serving. After the RSU grant, she directly holds 196,633 common shares.
Insider Trade Summary
Grant/Award: 89,300 shares
Grant/Award
2 txns
Insider
Smith Cynthia
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 53,600 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 35,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 53,600 contracts (Direct);
Common Stock — 196,633 shares (Direct)
Footnotes (2)
- F1. The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
- F2. The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
RSU grant: 35,700 units
Stock option grant: 53,600 shares
Option exercise price: $1.02 per share
+2 more
5 metrics
RSU grant
35,700 units
Restricted stock units granted on June 17, 2026
Stock option grant
53,600 shares
Option covering common stock granted on June 17, 2026
Option exercise price
$1.02 per share
Conversion/exercise price for the 53,600-share option
Option expiration
June 17, 2036
Scheduled expiration date of the stock option
Shares held after grant
196,633 shares
Direct common stock holdings after RSU grant
Key Terms
restricted stock units, 2023 Stock Incentive Plan, Non-Employee Director Compensation Program, Stock Option
4 terms
restricted stock units financial
"The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2023 Stock Incentive Plan financial
"were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan")"
Non-Employee Director Compensation Program financial
"as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program")"
Stock Option financial
"The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Akebia Therapeutics (AKBA) director Cynthia Smith receive?
Cynthia Smith received 35,700 restricted stock units and a stock option for 53,600 shares of Akebia common stock. Both awards were granted under the 2023 Stock Incentive Plan and the company’s non-employee director compensation program as part of her board compensation.
When do Cynthia Smith’s new Akebia (AKBA) RSUs and options vest?
Both the 35,700 restricted stock units and the 53,600-share stock option vest in full on the first anniversary of the June 17, 2026 grant date, or earlier immediately before the first annual stockholder meeting after that date, if she remains in continuous service.
What is the exercise price and term of Cynthia Smith’s Akebia stock option?
The stock option covers 53,600 shares of common stock at an exercise price of $1.02 per share. It becomes fully exercisable on the same vesting schedule as the RSUs and is scheduled to expire on June 17, 2036, if not exercised earlier.
Are Cynthia Smith’s recent Akebia equity awards open-market purchases or compensation grants?
The transactions are compensation-related grants, not open-market purchases. The Form 4 describes both the restricted stock units and the stock option as awards under Akebia’s 2023 Stock Incentive Plan and Fifth Amended and Restated Non-Employee Director Compensation Program for board service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates